Kara M. Kelly MD

Kara Kelly

Kara M. Kelly
MD

Professor and Division Chief, Hematology/Oncology

Department of Pediatrics

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Clinical Outcomes; Clinical Research; Health Services Research; Immunotherapy; Nutrition; Obesity; Pediatric Hematology-Oncology; Pediatrics

Contact Information
Roswell Park Comprehensive Cancer Center
Department of Pediatrics
Elm and Carlton Streets
Buffalo, New York 14263
Phone: (716) 845-2333
Fax: (716) 845-8003
kkelly24@buffalo.edu
View map


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD

Overview Research Publications Activities Latest News

Professional Summary:

Dr. Kara Kelly is the Waldemar J. Kaminski Endowed Chair of Pediatrics and Professor of Oncology at Roswell Park Comprehensive Cancer Center and Division Chief of Pediatric Hematology/Oncology at Oishei Children’s Hospital and the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo where she also is a Professor of Pediatrics. A pediatric oncologist with expertise in the care of children and adolescents with leukemia and lymphoma, Dr. Kelly chaired the Hodgkin lymphoma committee for the Children’s Oncology Group from 2011-2022. In this role, she oversaw the development and conduct of a large portfolio of clinical trials and correlative studies aimed at improving the care of children and adolescents with Hodgkin lymphoma through the integration of novel therapeutic strategies. Dr. Kelly remains active in this area, co-chairing a large phase 3 clinical trial comparing standard chemotherapy with a novel immunotherapy approach for children and adults with early stage Hodgkin lymphoma. Dr. Kelly is a member of the Scientific Advisory Board of the Lymphoma Research Foundation where she has focused on improving outcomes in adolescents and young adults with lymphoma. Dr. Kelly’s research interests also extend to pediatric acute lymphoblastic leukemia where she has been a long standing member of the Dana Farber Cancer Institute ALL Consortium, and leads studies investigating nutrition related factors contributing to treatment toxicity as well as development of interventions to improve adherence to oral chemotherapy.

Education and Training:
  • Fellowship, Pediatric Hematology/Oncology, University of Pennsylvania (1996)
  • Fellowship, Pediatric Hematology/Oncology, Hospital for Sick Children (1993)
  • Residency, Pediatrics, University of Pennsylvania (1992)
  • Internship, Pediatrics, University of Pennsylvania (1990)
  • MD, Medicine, University at Buffalo, Summa Cum Laude (1989)
  • BA, Human Biology, Brown University (1985)

Employment:
  • Chair, Roswell Park Comprehensive Cancer Center (2016-present)
  • Clinical Professor, Pediatrics, Columbia University College of Physicians and Surgeons (2016-present)
  • Division Chief, Hematology/Oncology, UBMD Pediatrics (2016-present)
  • Professor, Oncology, Roswell Park Comprehensive Cancer Center (2016-present)
  • Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2016-present)
  • Program Director, Pediatric Hematology/Oncology, Oishei Children‘s Hospital (2016-present)
  • Waldermar J. Kaminski Endowed Chair, Roswell Park Comprehensive Cancer Center (2016-present)
  • James A. Wolff Professor, Pediatrics, Columbia University College of Physicians and Surgeons (2015–2016)
  • Associate Director, Pediatric Hematology/Oncology/Stem Cell Transplantation, New York Presbyterian Morgan Stanley Children‘s Hospital (2012–2016)
  • Attending Physician, Pediatrics, New York Presbyterian Morgan Stanley Children‘s Hospital (2011–2016)
  • Professor, Pediatrics, Columbia University College of Physicians and Surgeons (2011–2016)
  • Clinic Attending, Pediatric Hematological Malignancies and Histiocytic Disorders, Herbert Irving Child and Adolescent Oncology Center (1996–2016)
  • Ward Attending, Pediatric Oncology, New York Presbyterian Morgan Stanley Children‘s Hospital (1996–2016)
  • Associate Attending, Pediatrics, New York Presbyterian Morgan Stanley Children‘s Hospital (2003–2011)
  • Associate Professor, Clinical Pediatrics, Columbia University College of Physicians and Surgeons (2003–2011)
  • Attending Pediatrician, Nyack Hospital (1996–2008)
  • Assistant Attending, Pediatrics, New York Presbyterian Morgan Stanley Children‘s Hospital (1996–2003)
  • Assistant Professor, Pediatrics, Columbia University College of Physicians and Surgeons (1996–2003)
See all (8 more)

Awards and Honors:
  • Distinguished Physician Award (2023)
  • Waldemar J. Kaminski Endowed Chair of Pediatrics (2016)
  • Columbia University College of Physicians and Surgeons: James A. Wolff Professorship of Pediatrics (2015)
  • New York Magazine: Top Doctors (2015)
  • National Cancer Institute: National Institute of Health Merit Award (2010)
  • Schneider Children's Hospital: Lefton Lectureship (2010)
  • Dana Farber Cancer Institute: 9th Annual Lenny Zakim Lecture - Invited Lectureship (2008)
  • Cincinnati Children‘s Hospital: Pediatric Grand Rounds and Visiting Professor (2005)
  • Babies & Children's Hospital of New York: Teacher of the Year Award (Runner-Up) (1998)
  • American Society of Clinical Oncology: Brigid Leventhal Merit Award (1996)
  • American Society of Pediatric Hematology/Oncology: Young Investigator Award in Oncology (1995)
  • Alpha Omega Alpha Medical Honor Society (1989)
  • University at Buffalo School of Medicine and Biomedical Sciences: Janet Glasgow Citation for Outstanding Women in Medicine (1989)
  • University at Buffalo School of Medicine and Biomedical Sciences: Frederick B. Wilkes Award in Pediatrics (1989)
  • University at Buffalo School of Medicine and Biomedical Sciences: Morris and Sadie Stein Neuroanatomy Award (1989)
  • James A. Gibson Anatomical Society (1989)
  • Sigma Xi National Science Honor Society (1986)
  • Best Doctors in America (2007-present)
  • Buffalo Spree Magazine: Top Doctors in Western New York (2019-2023)
  • Columbia Doctors: Board Governance - Elected Representative for Medical Specialties (2015-2016)
  • New York Super Doctors (2008-2016)
  • University at Buffalo School of Medicine and Biomedical Sciences: Dean's Letter of Commendation (1985-1988)

Research Expertise:
  • Acute lymphoblastic leukemia (ALL)
  • Adherence to oral chemotherapy
  • Cancer-related disparities in care
  • Hodgkin lymphoma
  • Nutrition
  • Symptom management

Grants and Sponsored Research:
  • April 2024–March 2029
    MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
    NIH/NCI
    Role: Co-Principal Investigator
  • August 2020–July 2025
    Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial
    National Cancer Institute
    Role: Contributor
  • April 2020–March 2025
    Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial.
    CIHR
    Role: Contributor
  • May 2024–May 2024
    Multimodal Learning for Contextually-Aware Longitudinal PET/CT Image Analysis
    NIH/NIBIB
    Role: Co-Investigator
  • March 2012–February 2024
    Children‘s Oncology Group Scientific Leadership Grant
    National Cancer Institute/Children‘s Hospital of Philadelphia
    Role: Co-Investigator
  • August 2020–June 2022
    National Childhood Cancer Registry (NCCR) Childhood Cancer Data Initiative (CCDI)
    NCI
    Role: Co-Principal Investigator
  • July 2019–June 2022
    Pediatric Cancer Data Commons
    St. Baldrick’s Foundation Consortium Grant
    Role: Co-Investigator
  • June 2017–June 2022
    The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships Across Time and Around Periods of Distress
    National Cancer Institute
    Role: Co-Investigator
    $2,868,886
  • July 2020–June 2021
    Genetic Basis for Ethnic Disparities of Bone Toxicities in Pediatric ALL
    Rally Foundation
    Role: Co-Investigator
  • December 2017–November 2019
    Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia
    National Cancer Institute
    Role: Co-Principal Investigator
    $200,000
  • May 2018–April 2019
    A Pilot Study Evaluating the Microbiome and Obesity in Pediatric Acute Lymphoblastic Leukemia
    Gabrielle's Angel Foundation
    Role: Co-Investigator
  • June 2017–June 2018
    A Comprehensive Assessment of Oral Chemotherapy Adherence in Pediatric ALL
    Roswell Park Alliance Foundation
    Role: Co-Principal Investigator
    $50,000
  • August 2014–February 2016
    Columbia University Minority/Underserved NCI Community Oncology Research Program
    National Cancer Institute
    Role: Principal Investigator
    $3,250,000
  • September 2012–February 2016
    Randomized Comparison of Intravenous CalaspargasePegol (SC-PEG asparaginase) and Intravenous Oncaspar in Children and Adolescents with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Dana Farber Cancer Institute, Harvard University, Sigma Tau Pharmaceuticals
    Role: Principal Investigator
    $97,300
  • July 2012–February 2016
    Integrative Therapies Program for Children with Cancer
    Ira Sohn Foundation
    Role: Principal Investigator
    $500,000
  • June 2012–May 2014
    Columbia University Medical Center Minority-Based Community Clinical Oncology Program
    National Cancer Institute
    Role: Co-Principal Investigator
    $2,388,906
  • January 2017
    The Relationships of Social Demographic Factors, Health Literacy and Social Network Characteristics on Oral Chemotherapy Adherence Through a Study Embedded in the DFCI ALL Consortium Clinical Trial
    Roswell Park Alliance Foundation
    Role: Co-Principal Investigator
    $50,000
See all (7 more)

Journal Articles:

See all (158 more)

Books and Book Chapters:

  • Roberts KB, Kelly KM, Constine LS. (2015) In: "Pediatric Hodgkin Lymphoma". Elsevier
  • Ladas EJ, Kelly KM. (2014) In: "The Antioxidant Debate". Oxford University Press, 317-348.
  • Rosenthal DS, Kelly KM, Abrams D. (2013) In: "Integrative Therapies in Patients with Hematologic Diseases". Elsevier, 2183-2190.
  • Ladas EJ, Kelly KM. (2011) Integrative Strategies for Cancer Patients: A Practical Resource for Managing the Side Effects of Cancer Therapy. World Scientific Publishing.
  • Jacobs SS, Kelly KM. (2011) In: "Integrative Therapies for Children with Hematological Malignancies". World Scientific Publishing
  • Kelly KM. (2010) In: "Oncologic Emergencies". Jones and Bartlett Publishers, LLC, 485-490.
  • Ladas EJ, Kelly KM. (2009) In: "The Antioxidant Debate". Oxford University Press
  • Ladas EJ, Kelly KM. (2007) In: "Complementary Therapies for Children with Cancer". Oxford University Press, 62-72.
  • Kelly KM. (2005) In: "Ewing's Sarcoma". Lippincott, Williams and Wilkins, Inc., 368-369.
  • Kelly KM. (2005) In: "Rhabdomyosarcoma". Lippincott, Williams and Wilkins, Inc., 728-729.
  • Kelly KM. (2005) In: "Histiocytic Disorders". Lippincott, Williams and Wilkins, Inc., 448-449.
  • Kelly KM. (2004) In: "Integrating Complementary Therapies in the Care of Children with Cancer: Research and Clinical Practice". , 614-619.
  • Ladas E, Kroll D, Kelly KM. (2004) In: "Milk Thistle". Marcel Dekker, Inc.
  • Kelly KM. (2003) In: Ewing's Sarcoma. Williams and Wilkins, Inc., 360-361.
  • Kelly KM. (2003) In: "Histiocytic Disorders". Williams and Wilkins, Inc., 438-439.
  • Kelly KM. (2003) In: "Rhabdomyosarcoma". Williams and Wilkins, Inc., 714-715.
  • Kelly KM. (2002) In: "Clinical Emergencies in Children with Cancer". Hanley and Belfus, Inc., 187-190.
  • Kelly KM. (2002) In: "Acute Lymphoblastic Leukemia". Hanley and Belfus, Inc., 109-114.
  • Kelly KM. (2002) In: "Acute Myeloid Leukemia". Hanley and Belfus, Inc., 115-120.
  • Kelly KM. (2002) In: "Langerhans Cell Histiocytosis". Hanley and Belfus, Inc., 141-144.
  • Kelly KM. (2000) In: "Langerhans Cell Histiocytosis". BC Decker, Inc., 2168-2170.
  • Kelly KM. (2000) In: "Histiocytic Disorders". Williams and Wilkins, Inc., 436-437.
  • Kelly KM. (2000) In: "Rhabdomyosarcoma". Williams and Wilkins, Inc., 708-709.
  • Kelly KM. (2000) In: "Aplastic Anemia". Williams and Wilkins, Inc., 132-133.
  • Kelly KM. (2000) In: "Hemophilia". Williams and Wilkins, Inc., 420-421.
  • Kelly KM. (2000) In: "Ewing's Sarcoma". Williams and Wilkins, Inc., 362-363.
  • Kelly KM, Friedman DF. (1999) In: "The Histiocytosis Syndromes". WB Saunders Company, 1129-1131.
  • Kelly KM. (1996) In: "Rhabdomyosarcoma". Williams and Wilkins, Inc., 662-663.
  • Kelly KM. (1996) In: "Aplastic Anemia". Williams and Wilkins, Inc., 92-93.
  • Kelly KM. (1996) In: "Ewing‘s Sarcoma". Williams and Wilkins, Inc., 322-323.
  • Kelly KM. (1996) In: "Hemophilia". Williams and Wilkins, Inc., 380-381.
  • Kelly KM. (1996) In: "Histiocytic Disorders". Williams and Wilkins, Inc., 398-399.
See all (22 more)

Abstracts:

  • Henderson TO, Castellino SM, Keller FG, Kelly KM, Curtis R, Conti RM, Parsons SK. (2016) Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents. Blood, (Jan) 3583-3583
  • Athale UH, Puligandla M, Stevenson KE, Asselin BL, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Harris MH, Neuberg DS, Sallan SE, Silverman LB. (2016) Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DAFCI) ALL Consortium Protocols 00-001 and 05-001. Blood, (Jan) 761-761
  • Marks LJ, Pei Q, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL. (2016) Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children‘s Oncology Group. Blood, (Jan) 1814-1814
  • Tran HT, Harris MH, Nguyen JV, Blonquist TM, Stevenson KE, Stonerock E, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Reshmi SC, Neuberg DS, Sallan SE, Loh ML, Silverman LB. (2016) Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): A Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium. Blood, (Jan) 1729-1729
  • Giulino-Roth L, Pei Q, Buxton A, Wolden S, Constine LS, Kelly KM, Schwartz CL, Friedman DL. (2016) Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children‘s Oncology Group Study AHOD0031. Blood, (Jan) 924-924
  • Silverman LB, Blonquist TM, Hunt SK, Kay-Green S, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Supko JG, He X, Hilderbrand S, Place AE, Vrooman LM, Harris MH, Stevenson KE, Neuberg DS, Sallan SE. (2016) Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-00. Blood, (Jan) 175-175
  • Kelly KM, Xie C, Chen L, Buxton A, Tan Y, Friedman DL, Schwartz CL, Zhao B, Schwartz L. (2013) Pretreatment and Interim Tumor Burden by CT Predicts Event-Free Survival in Children and Adolescents with Hodgkin Lymphoma (HL): A COG AHOD0031 Retrospective Study. Haematologica, (Jan) P115-P115
  • Chirindel A, Kim J, Chen L, Buxton A, Kessel S, Leal J, McCarten KM, Wolden SL, Schwartz CL, Friedman DL, Kelly KM, Cho SY. (2013) FDG PET-Based Parameters for Total Tumor Burden at Diagnosis are Highly Predictive for Outcome in Pediatric Hodgkin Lymphoma (HL): A COG AHOD0031 Retrospective Study. Haematologica, (Jan) P111-P111
  • Bradley MB, Harrison L, Cooney E, George D, Garvin J, Del Toro G, Bessmertny O, Cheung YK, Weiner M, Kelly KM, Gewanter R, Skerrett D, Martin PL, Kurtzberg J, Cairo MS. (2004) A Pilot Study of Myeloablative (MA) Autologous Stem Cell Transplantation (Auto SCT) Followed by Reduced Intensity (RI) Allogeneic Transplantation (Allo SCT) in Children and Young Adults with Relapsed/Refractory Lymphoma. Pediatr Blood Cancer, (Jan) PF005-PF005
  • Kelly KM, Hutchinson R, Sposto R, Weiner M, Lones M, Massey V. (2004) BEACOPP Chemotherapy is a Highly Effective Regimen in Children and Adolescents with Advanced Stage Hodgkin's Disease (HD): Results from Children's Cancer Study Group CCG-59704. Eur J Haematol, (Jan) WP07-WP07
  • Kelly KM, Hutchinson R, Sposto R, Weiner M, Lones M, Massey V. (2004) BEACOPP Chemotherapy is a Highly Effective Regimen in Children and Adolescents with Advanced Stage Hodgkin‘s Disease (HD): Results from Children‘s Cancer Group Study CCG-59704. Pediatr Blood Cancer, (Jan) O130-O130
  • Ladas EJ, Kennedy D, Li H, Kelly KM. (2003) Preliminary Findings: Dietary Folate and Methotrexate (MTX) Toxicity in Children with Acute Lymphoblastic Leukemia (ALL). Blood, (Jan) 1392-1392
  • Bradley MB, Harrison LA, Wolownik K, Weiner M, Kelly KM, Wischover C, Cairo MS. (2002) Myeloablative (MA) Autologous Stem Cell Transplantation (Auto SCT) Followed by Reduced Intensity (RI) Allogeneic Stem Cell Transplantation (Allo SCT) for Relapsed Hodgkin's Disease (HD). Ann Oncol, (Jan) 417-417
  • Shiramizu B, Morris E, Perkins S, Lones M, Kelly KM, Weiner M, Sposto R, Cairo MS. (2002) Identification of Patient Specific Primers (PSPs) of IgH and TCR-g Regions by Nested PCR in CD20 Positive Hodgin Disease: A Children's Cancer Group Report (CCG). Ann Oncol, (Jan) 389-389
  • Kelly KM, Hutchinson R, Sposto R, Weiner M, Lones M, Massey V. (2002) BEACOPP Chemotherapy is an Active and Feasible Regimen in Children and Adolescents with Advanced Stage Hodgkin's Disease: Preliminary Results from Children's Cancer Group Study CCG-59704. Blood, (Jan) 3070-3070
  • Reed Williams WL, Slater DJ, Rappaport EF, Lovett BD, Kelly KM, Osheroff N, Felix CA. (2001) Genomic Cloning and in vitro DNA Topoisomerase II Cleavage Assays Support in utero DNA Toperisomerase II-Mediated DNA Damage in MLL Translocation in Acute Myeloid Leukemia of Infant Twins. Blood, (Jan) 2346-2346
  • Kelly KM, Hutchinson R, Sposto R, Weiner M, Lones M, Massey V. (2001) Feasibility of Upfront Dose-Intensive Chemotherapy in Children with Advanced Stage Hodgkin's Disease: Children's Cancer Group Study CCG-59704. Leukemia and Lymphoma, (Jan) I48-I48
  • Lones MA, Perkins SL, Kelly KM, Weiner M, Morris E, Cairo MS. (2001) Targets for Bio-Immune Therapy in Classic Hodgkin's Disease in Children and Adolescents: Implications for Future Targeted Bio-Immune Therapy (TBIT) from Children's Cancer Group Study CCG-59704. Leukemia and Lymphoma, (Jan) P197-P197
  • Kennedy DD, Ladas E, Rheingold S, Weiner MA, Kelly KM. (2000) Antioxidant Deficiency in Children with Newly Diagnosed Acute Lymphoblastic Leukemia. Blood, (Jan) 1379-1379
  • Kelly KM, Jacobson JS, Kennedy DD, Weiner MA. (1998) Use of Complementary Therapies among Pediatric Oncology Patients at an Urban Medical Center. Proc Am Soc Clin Oncol, (Jan)
  • Leahey A, Kelly KM, Lange B. (1996) A Phase I Study of Idarubicin (Ida) with Continuous Infusion Fludarabine with Cytarabine (F-ara A/ara-C) for Refractory or Relapsed Pediatric Acute Myeloid Leukemia. Proc Am Soc Clin Oncol, (Jan)
  • Kelly KM, Womer RB, Sorenson P, Xiong QB, Barr FG. (1996) Common and Variant Gene Fusions Predict Clinical Phenotypes in Rhabdomyosarcoma. Proc Am Soc Clin Oncol, (Jan)
  • Kelly KM, Malone M, Milla P, Smith M, Fell J, Pritchard J. (1995) Colonic Involvement in Langerhans Cell Histiocytosis. Med Pediatr Oncol, (Jan) 141-141
  • Kelly KM, Beverley PC, Chu AC, Gordon I, Smith M, Pritchard J. (1995) Use of Anti-CD1a Antibody (NA1/34) for Immunolocalization in Langerhans Cell Histiocytosis. Med Pediatr Oncol, (Jan) 134-134
See all (14 more)

Professional Memberships:
  • American Society of Pediatric Hematology/Oncology (2023–present)
  • American Society of Clinical Oncology (2022–present)
  • American Society of Hematology (2009–present)
  • Children‘s Oncology Group (1997–present)
  • American Cancer Society: Fellow (1994–1996)

Presentations:
  • "Adolescent and Young Adult (AYA) Considerations for Hematologic Oncologists" Upstate New York Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting (2024)
  • "Advances in Pediatric Hematologic Malignancies: Lessons Learned from a Career in Clinical Research" University at Buffalo Jacobs School of Medicine and Biomedical Sciences Pediatric Grand Rounds (2024)
  • "Understanding Survivorship: When Lymphoma/CLL Treatment is Completed" Lymphoma Research Foundation Virtual Lymphoma Workshop (2024)
  • "Hodgkin Lymphoma in Children and Adolescents: Improving he Therapeutic Index" New York University Langone Hassenfeld Children’s Hospital Pediatric Grand Rounds (2023)
  • "Targeted Therapy and Immunotherapy for Pediatric Hodgkin Lymphoma" Saudi Arabian Society of Pediatric Hematology and Oncology Virtual Meeting (2023)
  • "AYA Lymphoma" Lymphoma Research Foundation North American Patient Education Conference (2023)
  • "Therapeutic Updates in Pediatric Hodgkin Lymphoma" 2nd Annual International Congress on Pediatric Oncology Virtual Meeting (2023)
  • "ICML Pediatric Subcommittee Report of the Revised Lugano Classification" 17th International Congress of Malignant Lymphoma Pre-Meeting Closed Workshop (2023)
  • "Therapeutic Updates for Newly Diagnosed Pediatric Hodgkin Lymphoma" v-SYMPHONY Virtual Lecture Series (2023)
  • "Therapeutic Advances for Pediatric Hodgkin Lymphoma" Inaugural International Congress of Pediatric Oncology (2022)
  • "Precision Medicine Advances for Pediatric Lymphomas" Precision Medicine in Hematological and Oncological Diseases: A Paradigm Shift Virtual Meeting (2022)
  • "AYA Lymphoma Drug Development Panel" Lymphoma Research Foundation AYA Lymphoma Workshop (2022)
  • "Hodgkin Lymphoma in Children and Adolescents" Taiwan Pediatric Oncology Group Annual Virtual Meeting (2022)
  • "Hodgkin Lymphoma in Children and Adolescents" King Faisal Specialist Hospital & Research Center 6th Pediatric Hematology/Oncology Updates Virtual Conference (2021)
  • "Hodgkin Lymphoma in Children and Adolescents" Mumbai Haematology Group Update in Lymphoma International Webinar, (2021)
  • "MDedge HemOnc Classical Hodgkin Lymphoma" Roundtable Recording (2021)
  • "Pediatric and Adult Hodgkin Lymphoma Perspectives" Women in Lymphoma Webinars (2021)
  • "Hodgkin Lymphoma in Children" King Faisal Specialist Hospital & Research Center 5th Pediatric Hematology Oncology Updates (2020)
  • "Infant CD19 Directed CAR-T Therapy" Media Interviews (2020)
  • "Hodgkin Lymphoma" Leukemia Lymphoma Society National Blood Cancer Conference (2020)
  • "Adolescent and Young Adult Lymphomas: Bridging the Divide" American Association of Cancer Research (AACR) Virtual Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application (2020)
  • "Long-term cancer survival rates improve among U.S. teens, young adults" Media Interview; Reuters Health (2020)
  • "Drug shortages hurt patients — and the hospitals that treat them" Media Interview; Buffalo Business First (2019)
  • "Bringing Innovative Therapies to Western New York: The Roswell Park Oishei Children’s Cancer and Blood Disorders Program" Olean Primary Care Providers Meeting (2019)
  • "Hodgkin Lymphoma in Children and Adolescents: Improving the Therapeutic Index" Pediatric Grand Rounds; Children‘s National Hospital (2019)
  • "Bringing Innovative Therapies to Western New York: The Roswell Park Oishei Children’s Cancer and Blood Disorders Program" Central New York Pediatric Club 100th Annual Meeting (2019)
  • "Collaboration and Conversation, Integrative Healthcare" McMaster Children’s Hospital Nutrition Days 2019 (2019)
  • "Cancer Crossings" Facebook Live; Roswell Park Comprehensive Cancer Center (2018)
  • "Exercise Cuts Late Mortality for Kids Who Beat Cancer" Media Interview; MedPage Today (2018)
  • "5 Things You Need to Know About Cancer and Food" Media Interview; In Good Health (2018)
  • "Bringing Evidence to Pediatric Integrative Oncology" Population Sciences Grand Rounds; Roswell Park Comprehensive Cancer Center (2018)
  • "Studies Offer New Insights into Treatment of Children, Adolescents with Hodgkin Lymphoma" Media Interview; Healio; HemOnc today (2018)
  • "Bringing Evidence to Complementary Therapies for Children with Cancer" Pediatric Grand Rounds; McMaster University (2018)
  • "Hodgkin Lymphoma in Children and Adolescents: Improving the Therapeutic Index" Hematology/Oncology Divisional Rounds; McMaster University (2018)
  • "Lymphoma Clinical Trials" North American Educational Forum on Lymphoma; Lymphoma Research Foundation (2017)
  • "Updates on Lymphoma" Facebook Live; Lymphoma Research Foundation (2017)
  • "Roswell Park: New Leukemia Treatment Needs More Time" Media Interview; Spectrum News (2017)
  • "Kids Cancer Support Group Rebrands, Expands with New Era‘s Help" Media Interview; Buffalo Business First (2017)
  • "The Personal Fight to Save Health Care Coverage" Media Interview; Spectrum News (2017)
  • "Diet in Children with Acute Lymphoblastic Leukemia Cohort Study: Developing Interventions to Reduce Obesity and Associated Complications" Scientific Retreat; Roswell Park Cancer Institute (2017)
  • "Nutrition Study Updates" ALL Investigator's Meeting; Dana Farber Cancer Institute (2017)
  • "Phase 2 Trial of Brentuximab Vedotin and Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma (HL): A Children’s Oncology Group (COG) Report" Annual Meeting; American Society of Clinical Oncology (2017)
  • "SEARCH for CAYAHL: COG Response Criteria" 3rd International Symposium on Childhood and Adolescent Hodgkin Lymphoma; St. Jude Children's Research Hospital (2017)
  • "Should Pediatric AYAs with Hodgkin Lymphoma be Treated Differently than Adult AYAs?" 14th International Ultmann Chicago Lymphoma Symposium; University of Chicago (2017)
  • "Adolescent/Young Adult Lymphomas: Issues in Clinical Research" Clinical Research Mentoring Program; Lymphoma Research Foundation (2017)
  • "Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage and Classical Hodgkin Lymphoma (cHL) in Children and Adolescents" Annual Meeting; American Society of Hematology (2016)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; University at Buffalo (2016)
  • "Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DAFCI) ALL Consortium Protocols 00-001 and 05-001" Annual Meeting; American Society of Hematology (2016)
  • "Hodgkin Lymphoma and T/NK Cell Lymphoma - Clinical Studies: Prognosis and Effects of Treatment in Hodgkin Lymphoma and Peripheral T-Cell Lymphomas" Annual Meeting; American Society of Hematology (2016)
  • "Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group" Annual Meeting; American Society of Hematology (2016)
  • "Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): A Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium" Annual Meeting; American Society of Hematology (2016)
  • "Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-00" Annual Meeting; American Society of Hematology (2016)
  • "Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031" Annual Meeting; American Society of Hematology (2016)
  • "Childhood Cancer Research Funding" Media Interview; WGRZ Channel 2 News (2016)
  • "Michael Buble‘s Son Diagnosed with Cancer" Media Interview; WGRZ Channel 2 News (2016)
  • "Adolescent and Young Adult Lymphomas" North American Educational Forum on Lymphoma; Lymphoma Research Foundation (2016)
  • "Hodgkin Lymphoma in Adolescents and Young Adults: Collaborative Efforts at Understanding Biology and Clinical Practice" 10th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2016)
  • "Hodgkin Lymphoma: Current and Future Management within the EURONET Framework" 48th Congress; International Society of Paediatric Oncology (2016)
  • "Integrative Approaches for NET Tumors" 4th Annual Conference on Neuroendocrine Tumors; Roswell Park Cancer Institute (2016)
  • "Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group" 10th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2016)
  • "Cancer Moonshot at Roswell Park" Media Interview; WBFO (2016)
  • "Oishei Children‘s Hospital Update" Media Interview; Kiss 98.5; Janet & Nick in the Morning (2016)
  • "Pediatric Cancer" Kaleida Health Medical Minute; WIVB (2016)
  • "RPCI-WCHOB Joint Program" Media Interview; Kiss 98.5; Janet & Nick in the Morning (2016)
  • "Differences in Approaches to Hodgkin Lymphoma Across the Adolescent and Young Adult Divide; Counterpoint: Pediatric Approach to Adolescent and Young Adult Hodgkin Lymphoma" Annual Meeting; American Society of Clinical Oncology; Education Session (2016)
  • "Pharmacogenomic Predictions of Treatment-Induced Severe Lung Toxicity in Hodgkin Lymphoma" Annual Meeting; American Society of Clinical Oncology (2016)
  • "Visceral Fat and Muscle Changes During 6-Week Chemotherapy in Pediatric Hodgkin Lymphoma" Annual Meeting; American Society of Clinical Oncology (2016)
  • "Bringing Evidence to Complementary Therapies for Children with Cancer" Fellows Academic Half-Day Seminar; Hospital for Sick Children (2016)
  • "Hodgkin Lymphoma in Children and Adolescents: Improving the Therapeutic Index" Hematology/Oncology Divisional Rounds; Hospital for Sick Children (2016)
  • "Pediatric Hematology/Oncology Updates" Media Interview; Variety Club; Variety Kids Telethon (2016)
  • "Tackling the Challenges of Adolescent and Young Adult Lymphoma" Erase Lymphoma Briefing; Capitol Hill (2016)
  • "Advances in the Treatment of Children and Adolescents with Hodgkin Lymphoma" Pediatric Grand Rounds; St. Barnabas Hospital (2015)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Woodhull Medical Center (2015)
  • "Hodgkin Lymphoma in Children and Adolescents" 57th Annual Meeting; American Society of Hematology; Education Session (2015)
  • "Adolescents and Young Adults with Lymphoma: Managing a Myriad of Issues - Acute Toxicities" 20th Annual North American Educational Forum on Lymphoma; Lymphoma Research Foundation (2015)
  • "Controversies in the Management of Pediatric Hodgkin Lymphoma: Battle of the Titans!" 28th Annual Meeting; American Society of Pediatric Hematology/Oncology (2015)
  • "Hodgkin Lymphoma in Children and Adolescents: New Initiatives Aimed at Improving the Quantity and Quality of Life" Invited Presentation; Roswell Park Cancer Institute (2015)
  • "Dilemmas and Decisions in Limited Stage Hodgkin Lymphoma" Webinar; American Society of Pediatric Hematology/Oncology (2015)
  • "Hodgkin Lymphoma: Treatment and Late Effects" ASCO University Focus Under Forty; American Society of Clinical Oncology (2015)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Center for Childhood Cancer Research Seminar Series; Children's Hospital of Philadelphia (2014)
  • "Dietary Intake of Zinc and Severity of Infection during Prophase/Induction in Children with Acute Lymphoblastic Leukemia" 56th Annual Meeting; American Society of Hematology (2014)
  • "Variants in PVTI are Associated with Susceptibility for Hodgkin Lymphoma in Children and Adolescents: A Children‘s Oncology Group Study" 56th Annual Meeting; American Society of Hematology (2014)
  • "Adult vs. Pediatric Perspectives on the Treatment of Hodgkin Lymphoma: An Oxford Debate" Multidisciplinary Symposium; Pediatric Oncology Group of Ontario (2014)
  • "Managing a Myriad of Toxicities in Adolescents with Lymphoma: Acute Toxicities" Multidisciplinary Symposium; Pediatric Oncology Group of Ontario (2014)
  • "Demographic Predictors of Use and Safety of Acupuncture in Children and Adolescents Undergoing Treatment for Cancer" Annual Meeting; Society for Integrative Oncology (2014)
  • "Clinical Research in Children with Cancer: Challenges and Opportunities" Annual Meeting; American Society of Clinical Oncology; Clinical Problems in Oncology (2014)
  • "Exploring the Role of Complementary and Alternative Therapies in Children: What We Know and Don't Know" Annual Meeting; Pheo Para Alliance (2014)
  • "Update from the Children‘s Oncology Group Hodgkin Lymphoma Committee" 2nd International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma; St. Jude's Children's Research Hospital (2014)
  • "Updates on Acute Lymphoblastic Leukemia" Pediatric Grand Rounds; Bronx Lebanon Hospital (2014)
  • "Results of the DFCI ALL Consortium Protocol 05-001 for Children and Adolescents with Newly Diagnosed ALL" 55th Annual Meeting; American Society of Hematology (2013)
  • "Acupuncture Therapy as Supportive Care fo Children, Adolescents and Young Adults (AYA) Undergoing Treatment for Cancer" National Conference and Exhibition; American Academy of Pediatrics (2013)
  • "Beyond the International Harmonization Criteria - New Challenges in the Application of Imaging Techniques for Staging and Response" 9th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2013)
  • "Children, Adolescents and Young Adults (AYA) Undergoing Treatment for Cancer Perceive Benefits to Acupuncture Therapy" Annual Meeting; Society for Integrative Oncology (2013)
  • "FDG PET-Based Parameters for Total Tumor Burden at Diagnosis are Highly Predictive for Outcome in Pediatric Hodgkin Lymphoma (HL): A COG AHOD0031 Retrospective Study" 9th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2013)
  • "Integrative Oncology for Symptom Management: State of the Evidence" 10th Annual International Conference; Society for Integrative Oncology (2013)
  • "Pretreatment and Interim Tumor Burden by CT Predicts Event-Free Survival in Children and Adolescents with Hodgkin Lymphoma (HL): A COG AHOD0031 Retrospective Study" 9th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2013)
  • "Variations in Dietary Intake among Children and Adolescents Undergoing Treatment for Acute Lymphoblastic Leukemia" Annual Meeting; Society for Integrative Oncology (2013)
  • "A Pilot Study Investigating the Effects of Glutamine and Vincristine-Induced Neuropathy in Pediatric Patients with Cancer" Annual Meeting; International Society of Pediatric Oncology (2013)
  • "Controversies in Hodgkin Lymphoma in Children and Adolescents: Updates from the Children's Oncology Group" Translational Cancer Research Seminar Series; Cincinnati Children's Hospital; Cancer and Blood Diseases Institute (2013)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; New York University Langone Medical Center (2013)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Bronx Lebanon Hospital (2013)
  • "Perceived Benefits of Acupuncture among Children and Adolescents Undergoing Treatment for Cancer" Annual Conference; Society for Acupuncture Research (2013)
  • "Traditional and Complementary Medicine" Annual Meeting; Central American Pediatric Hematology/Oncology Association (2013)
  • "FDG PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL): A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031" 54th Annual Meeting; American Society of Hematology (2012)
  • "Variations in Energy and Nutrient Specific Consumption Over the Course of Therapy in Children with Acute Lymphoblastic Leukemia" 54th Annual Meeting; American Society of Hematology (2012)
  • "Pediatric Hodgkin Lymphoma" Pediatric Grand Rounds; Maimonides Medical Center (2012)
  • "Albumin: A Predictor of EFS in MC Hodgkin Lymphoma" 44th Congress; International Society of Pediatric Oncology (2012)
  • "Conducting Research on Integrative Cancer Symptomology: Focus on Research Challenges, Successes and Resources in Clinical Research" 9th Annual International Conference; Society for Integrative Oncology (2012)
  • "Impact of IFRT among Pediatric Patients with Chemosensitive Hodgkin Lymphoma: A Subgroup Analysis of the COG AHOD0331 Study" 44th Congress; International Society of Pediatric Oncology (2012)
  • "Improving Our Understanding of Traditional Complementary/Alternative Medicine (TCAM) in Children with Cancer" Annual Meeting; Society for Integrative Oncology (2012)
  • "Integrative Health Care Practice Patterns, Policies and Procedures: A Survey among International Members of the Society for Integrative Oncology" 140th Annual Meeting; American Public Health Association (2012)
  • "Lifestyle Therapy Use in Pediatric Cancer Survivors" Annual Meeting; Society for Integrative Oncology (2012)
  • "Risk Factors for Bacteremia in Pediatric Patients with Cancer and Non-Neutropenic Fever" 44th Congress; International Society of Pediatric Oncology (2012)
  • "Topical Yunnan Baiyao Administration as an Adjunctive Therapy for Bleeding Complications in Children and Adolescents with Cancer" National Conference and Exhibition; American Academy of Pediatrics (2012)
  • "Use of Traditional Complementary/Alternative Medicine (TCAM) among Children with Cancer in Buenos Aires, Argentina" 44th Congress; International Society of Pediatric Oncology (2012)
  • "Conducting Research on Aromatherapy for Management of Cancer Symptoms" International Conference on Aromatherapy; Alliance of International Aromatherapists (2012)
  • "Pediatric Oncology: Current Concepts and Controversies" Webinar; GlobalCastMD (2012)
  • "Novel Symptom Management Strategies for Patients with Cancer: The Role of Integrative Approaches for Mitigating Toxicities" Invited Presentation; Osaka Graduate University (2012)
  • "Topical Yunnan Baiyao Administration as an Adjunctive Therapy for Bleeding Complications in Children and Adolescents with Cancer" Annual Meeting; Multinational Association of Supportive Care in Cancer (2012)
  • "Acupuncture is Acceptable to Children and Adolescents Undergoing Cancer Therapy" 2012 International Research Congress on Integrative Medicine and Health; Consortium of Academic Health Centers for Integrative Medicine (2012)
  • "Conducting Research on Integrative Cancer Symptomology: Focus on Research Challenges, Successes and Resources in Clinical Research" 2012 Congress; International Research Congress on Integrative Medicine and Health (2012)
  • "Controversies in Hodgkin Lymphoma in Children and Adolescents: Updates from the Children's Oncology Group" Pediatric Hematology/Oncology Divisional Conference; Doernbecher Children's Hospital (2012)
  • "Lifestyle Therapy Use in Pediatric Cancer Survivors" 2012 International Research Congress on Integrative Medicine and Health; Consortium of Academic Health Centers for Integrative Medicine (2012)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Hasbro Children‘s Hospital (2012)
  • "Novel Symptom Management Strategies for Patients with Cancer: The Role of Integrative Approaches for Mitigating Toxicities" Brown University Integrative Medicine Interest Group; Miriam Hospital (2012)
  • "Towards Improved Outcomes in the Care of Children and Adolescents with Cancer: Focus on Hodgkin Lymphoma" Invited Presentation; Beijing Children‘s Hospital (2012)
  • "Advances in the Treatment of Children and Adolescents with Hodgkin Lymphoma" Pediatric Grand Rounds; Northern Westchester Hospital (2012)
  • "Controversies in Hodgkin Lymphoma in Children and Adolescents: Updates from the Children's Oncology Group" New York Regional Education Series; Association of Pediatric Hematology/Oncology Nurses (2012)
  • "ITPCC: Fighting Chemotherapy Side Effects" Media Interview; WABC-TV; Eyewitness News (2011)
  • "Randomized Comparison of IV PEG and IM E.Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01" Annual Meeting; American Society of Hematology (2011)
  • "The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma" Annual Meeting; American Society of Hematology (2011)
  • "Acupuncture is Acceptable to Children and Adolescents Undergoing Cancer Therapy" 8th Annual Conference; Society for Integrative Oncology (2011)
  • "Mitigating Treatment Toxicity, Enhancing Treatment Efficacy: Strategies for Improved Symptom Management - Research and Clinical Practice" 8th International Conference; Society for Integrative Oncology (2011)
  • "The Development of an International Survey Exploring the Use of Traditional Complementary/Alternative Medicine (TCAM) in Children with Cancer" 8th Annual Conference; Society for Integrative Oncology (2011)
  • "The Integrative Therapies Program and Book Release" The Skillful Living Room; Dr. Michael Finkelstein (2011)
  • "Novel Symptom Management Strategies in Children with CNS Tumors: The Role of Complementary/Alternative Medicine" Annual Meeting; International Society of Pediatric Oncology (2011)
  • "Promotion of Healthy Lifestyles in Survivors of Childhood and AYA Cancer: Challenges and Opportunities" Annual Meeting; International Society of Pediatric Oncology (2011)
  • "The Development of an International Survey Exploring the Use of Traditional Complementary/Alternative Medicine (TCAM) in Children with Cancer" 2011 Congress; International Society of Pediatric Oncology (2011)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Staten Island University Hospital (2011)
  • "Best of the Society for Integrative Oncology" Integrative Healthcare Symposium (2011)
  • "Controversies in the Management of Pediatric Hodgkin Lymphoma" Invited Presentation (2010)
  • "Integrative Pediatric Oncology" Pediatric Grand Rounds; St. Joseph‘s Medical Center (2010)
  • "Low Dietary Intake of Calcium Associated with Increased Risk of Fracture in Males Undergoing Treatment for Acute Lymphoblastic Leukemia" 7th Annual Conference; Society for Integrative Oncology (2010)
  • "Use of Dietary Supplements among Children with Cancer in Guatemala" 7th Annual Conference; Society for Integrative Oncology (2010)
  • "Infection Control Practices during Induction Chemotherapy for ALL: Results of a Survey from the Dana Farber ALL Consortium" 2010 Congress; International Society of Pediatric Oncology (2010)
  • "Long-Term Outcome of Children and Adolescents with Hodgkin Lymphoma" 8th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2010)
  • "Low Dietary Intake of Calcium Associated with Increased Risk of Fracture in Males Undergoing Treatment for Acute Lymphoblastic Leukemia" 2010 Congress; International Society of Pediatric Oncology (2010)
  • "Management of Thromboembolism in Children and Adolescents with Acute Lymphoblastic Leukemia" 2010 Congress; International Society of Pediatric Oncology (2010)
  • "Use of Dietary Supplements among Children with Cancer in Guatemala" 2010 Congress; International Society of Pediatric Oncology (2010)
  • "Controversies in the Management of Pediatric Hodgkin Lymphoma" Invited Presentation; Children‘s Hospital of Westmead (2010)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Schneider Children‘s Hospital; Lefton Lectureship (2010)
  • "CANCER: Herb Milk Thistle Help Treat Liver Inflammation in Cancer Patients Who Receive Chemotherapy" ITPCC Study Findings Review; Medical News (2009)
  • "CANCER: Milk Thistle Cuts Liver Toxicity from ALL Chemotherapy" ITPCC Study Findings Review; MedPage Today (2009)
  • "CANCER: Milk Thistle May Limit Liver Damage from Chemo" ITPCC Study Findings Review; Reuters Health (2009)
  • "CANCER: Milk Thistle Protects Cancer Patients from Chemotherapy-Associated Liver Toxicity" ITPCC Study Findings Review; 7th Space Interactive (2009)
  • "CANCER: Milk Thistle Shows Potential in Helping Cancer Patients" ITPCC Study Findings Review; Los Angeles Times Health Blog (2009)
  • "Herb Could Ease Side Effects of Chemo" Media Interview; Fox News (2009)
  • "Integrative Medicine: Are You Treating the Whole Person?" Media Interview; ASH News Daily (2009)
  • "Integrative Therapies for Children with Hematologic Malignancies" Annual Meeting; American Society of Hematology; Education Session (2009)
  • "The Homeopathic Regimen, Ruta 6/Calc Phos, on Tumor Growth and Survival Using a PDGF Driven Rodent Model of Glioblastoma" 6th Annual Conference; Society for Integrative Oncology (2009)
  • "The Use of Traditional Complementary/Alternative Modalities (TCAM) among Children with Cancer Residing in Guatemala" 6th Annual Conference; Society for Integrative Oncology (2009)
  • "Traditional Complementary/Alternative Medicine (TCAM) Beliefs and Use among Children with Cancer in Guatemala" 137th Annual Meeting; American Public Health Association (2009)
  • "Cancer and Supplements: What Vitamins, Herbs and Botanicals Can (and Can‘t) Do" Media Interview; U.S. News and World Report (2009)
  • "Advances in Lymphoma in Children and Adolescents" Pediatric Grand Rounds; Jacobi Medical Center (2009)
  • "The Claim: Milk Thistle is Good for the Liver" Media Interview; New York Times (2009)
  • "Antioxidant Supplements during Cancer Therapy: What is the Clinical Evidence?" 9th Annual Lenny Zakim Lecture; Dana Farber Cancer Institute (2008)
  • "Integrative Medicine in Pediatric Oncology" Visiting Professor; Dana Farber Cancer Institute (2008)
  • "Bridging Diagnostic Relationships between Traditional Chinese Medicine (TCM) and Conventional Medicine in the Care of Children with Cancer" 5th Annual Conference; Society for Integrative Oncology (2008)
  • "Complementary/Alternative Medicine (CAM) Use by Survivors of Childhood Cancer" 5th Annual Conference; Society for Integrative Oncology (2008)
  • "Dietary Antioxidant Intake among Survivors of Childhood Cancer" 5th Annual Conference; Society for Integrative Oncology (2008)
  • "Fruit and Vegetable Intake in Survivors of Childhood Cancer" 5th Annual Conference; Society for Integrative Oncology (2008)
  • "Complementary/Alternative Medicine (CAM) Use by Survivors of Childhood Cancer" 136th Annual Meeting; American Public Health Association (2008)
  • "Research Studies in Traditional Chinese Medicine and Childhood Cancer" Shanghai International Symposium: Integrative Oncology Theory, Research and Practice; Society for Integrative Oncology (2008)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer" Office of Cancer and Complementary Medicine Monthly Lecture Series; National Cancer Institute (2007)
  • "A Pilot Study Investigating the Effects of Glutamine and Vincristine-Induced Neuropathy in Pediatric Patients with Cancer" 4th Annual Conference; Society for Integrative Oncology (2007)
  • "A Retrospective Review Investigating the Feasibility of Acupuncture as a Supportive Care Agent in a Pediatric Oncology Service" Annual Conference; Society for Acupuncture Research (2007)
  • "Acupuncture is Feasiblie in Children with Cancer with Low Platelet Counts" 4th Annual Conference; Society for Integrative Oncology (2007)
  • "Antioxidant Supplements during Cancer Therapy: What is the Clinical Evidence?" Integrative Medicine Program Lecture Series; MD Anderson Cancer Center (2007)
  • "Complementary/Alternative Medical (CAM) Therapies Use by Survivors of Childhood Cancer" 4th Annual Conference; Society for Integrative Oncology (2007)
  • "PET-Based Strategies in the Treatment of Childhood Hodgkin Lymphoma" Annual Meeting; International Society of Pediatric Oncology (2007)
  • "Complementary and Alternative Medicine for Pediatric Cancer" The Group Room; Vital Options International (2007)
  • "Dogs as Therapy for Kids" Media Interview; NBC; The Today Show (2007)
  • "Complementary and Alternative Medical Therapies for Children with Cancer" Childhood Cancer: Negotiating the Past, Planning the Future Conference (2007)
  • "Milk Thistle is Associated with Reductions in Liver Function Tests in Children Undergoing Therapy for Acute Lymphoblastic Leukemia" Annual Meeting; American Society of Hematology (2006)
  • "Pharmacogenetic Predictors of Toxicity in Dose-Intensive Therapy for Pediatric Advanced-Stage Hodgkin's Lymphoma" Annual Meeting; American Society of Hematology (2006)
  • "Refining the Therapy for Acute Lymphoblastic Leukemia: The Dana Farber Cancer Insititute ALL Consortium" New York Pediatric Hematology-Oncology-BMT Forum (2006)
  • "A Retrospective Review Investigating the Feasibility of Acupuncture as a Supportive Care Agent in a Pediatric Oncology Service" 3rd Annual Conference; Society for Integrative Oncology (2006)
  • "Bringing Evidence to Complementary and Alternative Medical Therapies for Children with Cancer: Focus on Nutrition Related Therapies" 2nd Puebla Conference on Nutrition and Childhood Cancer (2006)
  • "Milk Thistle (Silybum marianum) is Associated with Reductions in Liver Function Tests in Children Undergoing Therapy for Acute Lymphoblastic Leukemia" 3rd Annual Conference; Society for Integrative Oncology (2006)
  • "Promoting Research Guidelines for Natural Health Products (NHPs) in Oncology" 3rd Annual Conference; Society for Integrative Oncology (2006)
  • "Research Methods in Integrative Medicine: Challenges and Complexities" 3rd International Conference; Society for Integrative Oncology (2006)
  • "BEACOPP Chemotherapy in Children and Adolescents with Hodgkin's Disease" Trans-Atlantic Hodgkin's Clinical Trials Group (2006)
  • "Defiant and Exhausted: Teens Refuse Cancer Treatment" Media Interview; ABC; Health News (2006)
  • "BEACOPP Chemotherapy in Children and Adolescents with Hodgkin's Disease" Advisory Board Meeting; Sigma Tau (2006)
  • "Complementary and Alternative Medicine for Supportive Care in Pediatric Cancer" Annual Meeting; Multinational Association of Supportive Care in Cancer (2006)
  • "Lymphomas in the College Aged Student" Annual Meeting; American College Health Association (2006)
  • "Complementary and Alternative Medicine: The Integrative Therapies Program for Children with Cancer" Annual Meeting; Association of Pediatric Oncology Social Workers (2006)
  • "Developing Clinical Trials of Natural Health Products for Cancer Patients" North American Research Conference on Complementary and Integrative Medicine (2006)
  • "Bringing Evidence to Complementary and Alternative Medicine: The Integrative Therapies Program for Children with Cancer" Pediatric Grand Rounds; Brooklyn Hospital Center (2006)
  • "Predictors of Antioxidant Capacity (ORAC) in Siblings of Children Treated for Acute Lymphoblastic Leukemia" Annual Meeting; American Association of Cancer Research (2006)
  • "A Pilot Study of Myeloablative (MA) Autologous Stem Cell Transplantation (Auto SCT) Followed by Reduced Intensity (RI) Allogeneic Transplantation (Allo SCT) in Children and Adolescents with Relapsed Lymphoma" Annual Meeting; American Society of Bone Marrow Transplantation (2006)
  • "Treatments of Childhood Cancer in the 21st Century: The Successes, the Challenges" All Company Meeting; Eisai Research Institute (2006)
  • "Antioxidants" 2nd Annual Meeting; Society for Integrative Oncology (2005)
  • "Bringing Evidence to Complementary and Alternative Medicine: The Integrative Therapies Program for Children with Cancer" Pediatric Grand Rounds; Cincinnati Children‘s Hospital (2005)
  • "L‘Hopital pour enfants de New York, un modele a suivre?" Media Interview; PasseportSante.net (2005)
  • "Integrative Pediatric Oncology: Research and Clinical Perspectives" 3rd Annual Pediatric Integrative Medicine Conference (2005)
  • "Integrative Pediatric Oncology: Research and Clinical Perspectives" Pediatric Integrative Medicine Conference III; New York Medical College/University of Minnesota/Northwestern University (2005)
  • "Workshop B: Conducting Pediatric CAM Research" Pediatric Integrative Medicine Conference III; New York Medical College/University of Minnesota/Northwestern University (2005)
  • "False Positive FDG-PET Scans are Highly Prevalent during Follow-Up for Pediatric Hodgkin's Disease" 2005 Congress; Society for Integrative Oncology (2005)
  • "Complementary and Alternative Therapies for Children with Cancer" Annual Meeting; Children's Neuroblastoma Cancer Foundation (2005)
  • "Myeloablative (MA) Autologous Stem Cell Transplantation (auto SCT) Followed by Reduced Intensity (RI) Allogeneic SCT (allo SCT) in Children and Adolescents with Poor Risk Relapsed Lymphoma" 9th International Conference on Malignant Lymphoma; Union for International Cancer Control (2005)
  • "The Sensitivity of Whole-Body Positron Emission Tomography in the Diagnosis and Follow-Up of Pediatric Patients with Hodgkin's Disease: A Retrospective Pilot Study" 52nd Annual Meeting; Society of Nuclear Medicine (2005)
  • "A Comparison of Toxicity and Outcome Following BEACOPP Therapy in Adolescents and Young Adults with Hodgkin's Disease (HD) by Pediatric and Adult Oncology Cooperative Groups" Annual Meeting; American Society of Clinical Oncology (2005)
  • "Carotid Artery Intima-Media Thickness is Associated with History of Hodgkin‘s Disease" Annual Meeting; American Society of Clinical Oncology (2005)
  • "Restoring the Spirit and Sharing the Vision" Oncology Nursing Conference; Miller‘s Children‘s Hospital (2005)
  • "Integrating Integrative Therapies - Where Is It Going and Who Is Going to Pay?" Annual Conference; American Pediatric Association (2005)
  • "Complementary Therapies for Children with Cancer" Families ROCK Weekend; American Cancer Society (2004)
  • "A Pilot Study of Myeloablative (MA) Autologous Stem Cell Transplantation (Auto SCT) Followed by Reduced Intensity (RI) Allogeneic Transplantation (Allo SCT) in Children and Young Adults with Relapsed/Refractory Lymphoma" 2004 Congress; International Society of Pediatric Oncology (2004)
  • "BEACOPP Chemotherapy is a Highly Effective Regimen in Children and Adolescents with Advanced Stage Hodgkin‘s Disease (HD): Results from Children‘s Cancer Group Study CCG-59704" 2004 Congress; International Society of Pediatric Oncology (2004)
  • "BEACOPP Chemotherapy is a Highly Effective Regimen in Children and Adolescents with Advanced Stage Hodgkin‘s Disease (HD): Results from Children‘s Cancer Group Study CCG-59704" 6th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2004)
  • "BEACOPP Chemotherapy of Adolescents by Adult and Pediatric Groups" 6th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2004)
  • "Complementary and Alternative Therapies for Children with Cancer" Annual Meeting; International Society of Pediatric Oncology (2004)
  • "A Pilot Study Comparing Bone Mass in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) to Healthy Controls" 8th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer; American Society of Clinical Oncology (2004)
  • "Integrating Complementary Therapies in the Care of Children with Cancer: Research and Clinical Practice" Annual Meeting; American Society of Clinical Oncology; Education Session (2004)
  • "Long-Term Effects of Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia" Symposium: Educational Issues in Childhood Cancer; Leukemia and Lymphoma Society (2004)
  • "Critique on Complementary and Alternative Therapies Research in Children with Cancer" State of the Science Summit II; Children's Oncology Group Nursing Committee (2004)
  • "Integrative Therapies for Children" Pediatric Grand Rounds; Hackensack University Medical Center (2004)
  • "Preliminary Findings: Dietary Folate and Methotrexate (MTX) Toxicity in Children with Acute Lymphoblastic Leukemia (ALL)" Annual Meeting; American Society of Hematology (2003)
  • "Antioxidant Status Decreases in Children with Acute Lymphoblastic Leukemia during the First Six Months of Chemotherapy Treatment" Free Radicals: The Pros and Cons of Antioxidants Meeting (2003)
  • "Antioxidants and Cancer Therapy: A Systematic Review" Free Radicals: The Pros and Cons of Antioxidants Meeting (2003)
  • "Research on the Fringe: Integrative Therapies for Children with Cancer" Nursing Plenary Meeting; Children's Oncology Group (2003)
  • "Integrative Therapies in Children with Cancer" Pediatric Grand Rounds; St. Vincent‘s Medical Center (2003)
  • "BEACOPP Chemotherapy is an Active and Feasible Regimen in Children and Adolescents with Advanced Stage Hodgkin's Disease: Preliminary Results from Children's Cancer Group Study CCG-59704" Annual Meeting; American Society of Hematology (2002)
  • "Management of Advanced Hodgkin's Disease in Children and Adolescents" Symposium: Childhood and Adolescent Leukemia and Lymphoma - Genetics to Therapeutics; Leukemia and Lymphoma Society (2002)
  • "Complementary Therapies Use in Children with Cancer" Pediatric Grand Rounds; St. Joseph‘s Children‘s Medical Center (2002)
  • "VOD and Recurrent Fever in Pediatric Patients Receiving Vincristine and Actinomycin D Only for Treatment of Rhabdomyosarcoma" Annual Meeting; American Society of Pediatric Hematology/Oncology (2002)
  • "A Pilot Study of Myeloablative (MA) Autologous Stem Cell Followed by Reduced Intensity (RI) Allogeneic Transplantation in Children and Young Adults with Relapsed Lymphoma" Annual Meeting; American Society of Bone Marrow Transplantation (2002)
  • "Genomic Cloning and in vitro DNA Topoisomerase II Cleavage Assays Support in utero DNA Toperisomerase II-Mediated DNA Damage in MLL Translocation in Acute Myeloid Leukemia of Infant Twins" Annual Meeting; American Society of Hematology (2001)
  • "Langerhans Cell Histiocystosis" Pediatric Grand Rounds; Jacobi Medical Center (2001)
  • "Children‘s Cancer Group-59704: Feasibility of Upfront Dose Intensive Chemotherapy in Children with Advanced Stage Hodgkin‘s Disease" 5th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2001)
  • "Feasibility of Upfront Dose-Intensive Chemotherapy in Children with Advanced Stage Hodgkin‘s Disease: Children‘s Cancer Group Study CCG-59704" 5th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2001)
  • "Polymorphisms of Drug Metabolizing Enzymes and Markers of Genotoxicity to Identify Patients at Risk of Treatment-Related Complications" 5th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2001)
  • "Targets for Bio-Immune Therapy in Classic Hodgkin‘s Disease in Children and Adolescents: Implications for Future Targeted Bio-Immune Therapy (TBIT) from Children‘s Cancer Group Study CCG-59704" 5th International Symposium on Hodgkin Lymphoma; German Hodgkin Study Group (2001)
  • "Use of Complementary Therapies by Children with Cancer" 21st Annual Cancer Symposium: Integrating Complementary Medicine into the Care of Your Cancer Patient (2001)
  • "BEACOPP in Children with Advanced Stage Hodgkin's Disease" International Hodgkin's Disease Task Force Meeting (2000)
  • "Case Summary" Ascending Neuropathy Following Intrathecal Chemotherapy Meeting; National Cancer Institute (2000)
  • "Complementary and Alternative Medical Therapies in Pediatric Oncology" Comprehensive Cancer Care 2000: Integrating Complementary and Alternative Therapies (2000)
  • "Complementary Therapies Use in Children with Cancer" Pediatric Grand Rounds; Lincoln Hospital (2000)
  • "Complementary Therapies Use in Children with Cancer" Visiting Professor; University of Minnesota (1999)
  • "Controversies Surrounding Antioxidant Supplementation among Children on Therapy for Acute Lymphoblastic Leukemia" Pediatric Oncology Seminar; Children's Hospitals and Clinics (1999)
  • "Antioxidants and Oxidative Status in Children with Acute Lymphoblastic Leukemia" Leukemia and Stem Cell Biology Seminar; Children's Hospital of Philadelphia (1998)
  • "Complementary Therapies Use in Children with Cancer" Pediatric Grand Rounds; Holy Name Hospital (1998)
  • "An Integrative Therapies Program for Children with Cancer" Integrating Complementary Therapies for Cancer Conference; Cambridge Health Resources (1998)
  • "Complementary and Alternative Medical Therapies for Children with Cancer" Pediatric Grand Rounds; Valley Hospital (1997)
  • "Complementary and Alternative Medicine Use in Children with Cancer" Pediatric Grand Rounds; Pascack Valley Hospital (1997)
  • "Acute Myeloid Leukemia in Childhood" New Jersey Chapter Annual Meeting; Association of Pediatric Oncology Nurses (1997)
  • "A Phase I Study of Idarubicin (Ida) with Continuous Infusion Fludarabine with Cytarabine (F-ara A/ara-C) for Refractory or Relapsed Pediatric Acute Myeloid Leukemia" Annual Meeting; American Society of Clinical Oncology (1996)
  • "Common and Variant Gene Fusions Predict Clinical Phenotypes in Rhabdomyosarcoma" Annual Meeting; American Society of Clinical Oncology (1996)
  • "Superior in vivo Recovery with Recombinant Factor VIII Concentrate in Children with Hemophilia" Annual Meeting; American Pediatric Societies (1996)
  • "Use of Anti-CD1a Antibody (NA1/34) for Immunolocalization in Langerhans Cell Histiocytosis" 9th Annual Meeting; Histiocyte Society (1995)
See all (250 more)

Service Activities:
  • Lymphoma Research Foundation Adolescent and Young Adult Lymphoma Consortium; Co-chair, Executive Committee Member (2023–present)
  • Pediatric Chair Search; Member, Search Committee (2023–present)
  • 5th International Symposium on Childhood Adolescent, and Young Adult Hodgkin Lymphoma; Member, Scientific Committee (2023)
  • 17-ICML Closed Workshop: Lugano Classification: Looking Towards the Future; Chair, Pediatric Subcommittee (2022–2023)
  • AACR Pediatric Cancer Review Panel; Grant Reviewer (2022–2023)
  • NCTN AYA Trials Publications Task Force; Co-Chair (2022)
  • Children's Oncology Group AHOD2131; Co-chair (2021–present)
  • NODAL (Hodgkin Lymphoma Data Collaboration); Co-Chair, Executive Committee (2020–present)
  • Lymphoma Research Foundation: Adolescent/Young Adult Lymphoma Scientific Workshop; Co-Chair (2019)
  • Children's Oncology Group AHOD1822; Scientific Steering Committee Member (2018–present)
  • National Cancer Institute: Physician Data Query; Advisory Board (2018–2023)
  • Jacobs School Tenurial Promotions Committee (2018–2021)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Department Chair of Pediatrics; Committee Member (2018)
  • American Society of Hematology: Clinical Research Training Institute - Latin America Faculty Member; Faculty Member (2018)
  • National Cancer Institute: Physician Data Query Pediatric Treatment; Editorial Board Member (2018–present)
  • Lymphoma Research Foundation: North American Educational Forum on Lymphoma; Co-Chair (2017)
  • Lymphoma Research Foundation: Clinical Mentoring Program Subcommittee Faculty Member; Faculty Member (2017–2021)
  • Penn State University CTSI: KL2; Grant Reviewer (2017)
  • American Society of Hematology: Scholar Awards Clinical Study Section; Grant Reviewer (2017)
  • American Society of Hematology Annual Meeting: 'Lymphoma Clinical Trials' Session; Moderator (2016)
  • International Society of Paediatric Oncology 48th Annual Congress: Keynote Lecture Session; Chair (2016)
  • Erase Lymphoma Capitol Hill Briefing: “Tackling the Challenges of Adolescent and Young Adult Lymphoma”, Cannon House Office Building, Co-sponsors: Representative Zeldin (R-NY), Representative Capps (D-CA); Discussant (2016–present)
  • Department of Pediatric Promotions Review Committee (2016–present)
  • American Society of Hematology: Annual Meeting Abstracts; Reviewer (2016)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (AHOD1721); Committee Member (2016–present)
  • Roswell Park Comprehensive Cancer Center: Cancer Center Support Grant Steering Committee; Committee Member (2016–present)
  • Blood Advances; Editorial Board Member (2016–present)
  • Dana Farber Cancer Institute: Acute Lymphoblastic Leukemia Consortium (Roswell Park Comprehensive Cancer Center); Member (2016–present)
  • American Society of Hematology Annual Meeting: 'Hodgkin Lymphoma in Children and Adolescents' Session; Chair (2015)
  • American Society of Hematology Annual Meeting: 'Pediatric Hematological Malignancies: Beyond ALL' Session; Chair (2015)
  • Society for Integrative Oncology 12th International Conference: ‘Meditation Practices along the Cancer Care Continuum...' Session; Moderator (2015)
  • Lymphoma Research Foundation: Scientific Advisory Board; Board Member (2015–2024)
  • 3rd International Symposium on Childhood Adolescent and Young Adult Hodgkin Lymphoma: Scientific Committee; Committee Member (2015–2017)
  • Children‘s Oncology Group: Cancer Control and Supportive Care NCORP Committee; Committee Member (2015–2016)
  • Columbia University College of Physicians and Surgeons: Search Committee for Radiation Oncology Chair; Committee Member (2015)
  • Children‘s Oncology Group: Cancer Care Delivery Research Review Committee; Committee Member (2015–present)
  • Lymphoma Research Foundation; Grant Reviewer (2015–present)
  • Children‘s Oncology Group: Cancer Care Delivery Research; Reviewer (2015–present)
  • American Society of Hematology: Clinical Research Training Institute Faculty Member and Small Group Leader; Faculty Member (2014–2018)
  • Columbia University College of Physicians and Surgeons: Search Committee for Pediatric Palliative Care Program Medical Director; Chair (2014)
  • National Cancer Institute: Hodgkin Lymphoma Subcommittee; Committee Member (2014)
  • National Cancer Institute: Lymphoma Steering Committee; Committee Member (2014)
  • National Cancer Institute: Clinical Investigator Team Leadership Award; Grant Reviewer (2014)
  • Lymphoma Research Foundation: Adolescent/Young Adult Lymphoma Initiative Scientific Planning Committee; Co-Chair (2014–present)
  • Lymphoma Research Foundation: Advisory Committee; Committee Member (2014–present)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (AHOD1431/A051305); Committee Member (2013–2014)
  • Children‘s Oncology Group: Cancer Control and Supportive Care CCOP Committee; Committee Member (2013–2014)
  • Columbia University College of Physicians and Surgeons: Strategic Planning Group for Irving Pavilion Improvements; Committee Member (2013)
  • CureSearch Foundation; Grant Reviewer (2013)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (AHOD1331); Committee Member (2013–present)
  • Society for Integrative Oncology; Past President (2012–2013)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (AHOD1221); Committee Member (2012–2018)
  • Morgan Stanley Children‘s Hospital/Beijing Children‘s Hospital: Exchange Program; Coordinator (2012–2015)
  • 2nd International Symposium on Childhood Adolescent and Young Adult Hodgkin Lymphoma: Scientific Committee; Committee Member (2012–2014)
  • Columbia University College of Physicians and Surgeons: Implementation of the Academic Tracks Committee; Committee Member (2012–2013)
  • Society for Integrative Oncology; President (2011–2012)
  • International Society of Pediatric Oncology Annual Meeting: Symposium 6 (Auckland, New Zealand); Co-Chair (2011)
  • Children‘s Oncology Group: Cancer Control and Supportive Care Study Committee (ACCL1032); Vice-Chair (2011–2012)
  • Children‘s Oncology Group: Hodgkin Lymphoma Committee; Chair (2011–present)
  • Children‘s Oncology Group: Scientific Chairs Committee; Committee Member (2011–present)
  • Society for Integrative Oncology President-Elect (2010–2011)
  • Adam R. Spector Foundation for Support of Research in Hodgkin Lymphoma; Advisory Board (2010–2016)
  • Columbia University Medical Center: Pediatric Residency Research Oversight Committee; Committee Member (2010–2014)
  • Columbia University Medical Center: Pediatric Leadership Academy; Member (2010–2011)
  • Society for Integrative Oncology 7th International Conference: Ayurveda Workshop; Chair (2010)
  • Society for Integrative Oncology 7th International Conference: Scientific Program Committee; Committee Member (2010)
  • Society for Integrative Oncology: Executive Board; Secretary (2009–2010)
  • Society for Integrative Oncology: 6th Annual Scientific Meeting; Chair (2009)
  • International Society of Pediatric Oncology Annual Meeting: Symposium 11 (Sao Paulo, Brazil); Co-Chair (2009)
  • Columbia University Medical Center: Pediatric Faculty Development Committee; Committee Member (2009–2013)
  • Columbia University College of Physicians and Surgeons: Pediatric Chairman‘s Advisory Council; Member (2009–2013)
  • International Society of Pediatric Oncology: Scientific Program Advisory Committee; Committee Member (2009–2011)
  • Journal of the Society of Integrative Oncology; Associate Editor (2009–2010)
  • Society for Integrative Oncology 6th International Conference: Scientific Program Committee; Chair (2009)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (AHOD0831); Chair (2009–present)
  • Society for Integrative Oncology: 5th Annual Scientific Meeting; Co-Chair (2008)
  • Children‘s Oncology Group: Cancer Control and Supportive Care Steering Committee; Committee Member (2008–2017)
  • Columbia University College of Physicians and Surgeons: Women Faculty Advisory Committee; Committee Member (2008–2016)
  • Columbia University College of Physicians and Surgeons: Advisory Committee on Faculty Professional Development; Committee Member (2008–2009)
  • International Society of Pediatric Oncology Annual Meeting: Symposium (Mumbai, India); Chair (2007)
  • Columbia University College of Physicians and Surgeons: Scholarly Oversight Committee for Pediatric Hematology/Oncology Fellows; Committee Member (2007–2012)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center - Lymphoid Neoplasia Program; Member (2007–present)
  • Journal of Pediatric Hematology/Oncology; Associate Editor (2006–2012)
  • Columbia University College of Physicians and Surgeons: Faculty Practice Organization Nominating Committee; Committee Member (2006)
  • Society for Integrative Oncology; Board of Directors (2006–present)
  • Columbia University: Search Committee for Associate Provost for Work-Life Issues; Committee Member (2005)
  • Children‘s Oncology Group: Cancer Control and Supportive Care Study Committee (ACCL04C2); Chair (2004–2009)
  • Columbia University Medical Center: Ad Hoc Committee on Pediatric Faculty Development; Chair (2004–2008)
  • Sick Kids Foundation: National Grants Committee - Grants Review Committee; Committee Member (2004)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center - Protocol Review and Monitoring Committee; Chair (2003–2004)
  • 6th International Symposium on Hodgkin‘s Lymphoma: Scientific Committee; Committee Member (2003–2004)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center - Prevention, Control and Disparities Program; Member (2002–present)
  • Dana Farber Cancer Institute: Acute Lymphoblastic Leukemia Consortium (Columbia University Medical Center); Member (2001–2016)
  • Children‘s Oncology Group: Cancer Control and Supportive Care Adolescent and Young Adult Committee; Committee Member (2001–2009)
  • Columbia University College of Physicians and Surgeons: Pediatric Resident Web-Based Curriculum Virtual Preceptor (2001–2008)
  • National Insititutes of Health: Antioxidant Concurrent Use with Chemotherapy and Radiotherapy Workshop Planning Committee; Committee Member (2001)
  • Children‘s Oncology Group: Hodgkin Lymphoma Steering Committee; Committee Member (2001–present)
  • National Cancer Institute: Physician Data Query Cancer Complementary and Alternative Medicine; Editorial Board Member (2001–present)
  • Columbia University College of Physicians and Surgeons: Task Force for Women in Medicine; Co-Chair (2000–2005)
  • Children's Oncology Group: Cancer Control and Supportive Care; Member (2000–2002)
  • Children‘s Oncology Group: Acute Lymphoblastic Leukemia (CCG 1991); Committee Member (1999–2001)
  • Children‘s Oncology Group: Cancer Control and Supportive Care Complementary Theories Subcommittee; Chair (1998–2011)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center; Member (1997–2016)
  • Columbia University Medical Center: Integrative Therapies Program for Children with Cancer Medical Director (1997–2013)
  • Integrative Therapies Program for Children with Cancer Medical Director (1997–2013)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center - Protocol Review and Monitoring Committee; Committee Member (1997–2013)
  • Children‘s Oncology Group: Hodgkin Lymphoma Study Committee (CCG59704); Chair (1997–2010)
  • Columbia University College of Physicians and Surgeons: Herbert Irving Comprehensive Care Center - Experimental Therapeutics Program; Member (1997–2006)
  • Columbia University College of Physicians and Surgeons: Faculty Council (2001-2004, 2007-2010) Voting Member
  • Columbia University College of Physicians and Surgeons: Annual Forums for Medical Students (2000, 2002, 2003) Pediatric Oncology Faculty Representative
  • Pediatric ALL NCCN Guidelines; Panel Member
  • Pediatric Hodgkin Lymphoma NCCN Guidelines; Panel Member
  • American Journal of Hematology; Reviewer
  • Cancer; Reviewer
  • Cancer Practice; Reviewer
  • Blood; Reviewer
  • European Journal of Cancer; Reviewer
  • Journal of Clinical Oncology; Reviewer
  • Journal of Pediatric Hematology/Oncology; Reviewer
  • Journal of the American Medical Association; Reviewer
  • Journal of the National Cancer Institute; Reviewer
  • Leukemia and Lymphoma; Reviewer
  • Leukemia Research; Reviewer
  • Pediatric Blood and Cancer; Reviewer
  • Supportive Care in Cancer; Reviewer

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Roswell Park Comprehensive Cancer Center
Department of Pediatrics
Elm and Carlton Streets
Buffalo, New York 14263
Phone: (716) 845-2333
Fax: (716) 845-8003
kkelly24@buffalo.edu
View map

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD
Login to Update Your Profile